{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:56:09Z","timestamp":1789973769029,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T00:00:00Z","timestamp":1463356800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1543-x","type":"journal-article","created":{"date-parts":[[2016,5,15]],"date-time":"2016-05-15T21:28:49Z","timestamp":1463347729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection"],"prefix":"10.1186","volume":"16","author":[{"given":"Shu-Ling","family":"Huan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Guang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,16]]},"reference":[{"key":"1543_CR1","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.jss.2010.04.004","volume":"163","author":"GA Roth","year":"2010","unstructured":"Roth GA, Zimmermann M, Lubsczyk BA, et al. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure. J Surg Res. 2010;163:e79\u201383.","journal-title":"J Surg Res"},{"key":"1543_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12250-014-3412-3","volume":"29","author":"J Chen","year":"2014","unstructured":"Chen J, Yuan Z. Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies. Virol Sin. 2014;29:17\u201324.","journal-title":"Virol Sin"},{"key":"1543_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-0711-4-13","volume":"4","author":"SD Crockett","year":"2005","unstructured":"Crockett SD, Keeffe EB. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob. 2005;4:13.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1543_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","volume":"5","author":"B Rehermann","year":"2005","unstructured":"Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215\u201329.","journal-title":"Nat Rev Immunol"},{"key":"1543_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/s-2000-9946","volume":"20","author":"B Rehermann","year":"2000","unstructured":"Rehermann B. Interaction between the hepatitis C virus and the immune system. Semin Liver Dis. 2000;20:127\u201341.","journal-title":"Semin Liver Dis"},{"key":"1543_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/039463200501800402","volume":"18","author":"MI Gonzalez","year":"2005","unstructured":"Gonzalez MI, Rubinstein N, Ilarregui JM, Toscano MA, Sanjuan NA, Rabinovich GA. Regulated expression of galectin-1 after in vitro productive infection with herpes simplex virus type 1: implications for T cell apoptosis. Int J Immunopathol Pharmacol. 2005;18:615\u201323.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1543_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/039463200501800209","volume":"18","author":"F Martini","year":"2005","unstructured":"Martini F, Agrati C, D'Offizi G, Poccia F. HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells. Int J Immunopathol Pharmacol. 2005;18:269\u201376.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1543_CR8","first-page":"144","volume":"36","author":"K Falasca","year":"2006","unstructured":"Falasca K, Ucciferri C, Dalessandro M, et al. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci. 2006;36:144\u201350.","journal-title":"Ann Clin Lab Sci"},{"key":"1543_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000329932","volume":"35","author":"AE Grzegorzewska","year":"2012","unstructured":"Grzegorzewska AE, Wobszal P, Jagodzinski PP. Interleukin-18 promoter polymorphism and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients. Kidney Blood Press Res. 2012;35:1\u20138.","journal-title":"Kidney Blood Press Res"},{"key":"1543_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/jir.2011.0109","volume":"32","author":"J Wang","year":"2012","unstructured":"Wang J, Cai Y, Ji H, et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. J Interferon Cytokine Res. 2012;32:248\u201353.","journal-title":"J Interferon Cytokine Res"},{"key":"1543_CR11","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","volume":"61","author":"A Bertoletti","year":"2012","unstructured":"Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut. 2012;61:1754\u201364.","journal-title":"Gut"},{"key":"1543_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.antiviral.2012.10.001","volume":"96","author":"J Chang","year":"2012","unstructured":"Chang J, Block TM, Guo JT. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy. Antiviral Res. 2012;96:405\u201313.","journal-title":"Antiviral Res"},{"key":"1543_CR13","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/hep.20956","volume":"43","author":"HJ Yim","year":"2006","unstructured":"Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006;43:S173\u201381.","journal-title":"Hepatology"},{"key":"1543_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","volume":"6","author":"YF Liaw","year":"2012","unstructured":"Liaw YF, Kao JH, Piratvisuth T, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int. 2012;6:531\u201361.","journal-title":"Hepatol Int"},{"key":"1543_CR15","first-page":"143026","volume":"2010","author":"Y Jiang","year":"2010","unstructured":"Jiang Y, Ma Z, Xin G, et al. Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators Inflamm. 2010;2010:143026.","journal-title":"Mediators Inflamm"},{"key":"1543_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003331","volume":"3","author":"C Moussion","year":"2008","unstructured":"Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One. 2008;3, e3331.","journal-title":"PLoS One"},{"key":"1543_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479\u201390.","journal-title":"Immunity"},{"key":"1543_CR18","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s00134-004-2184-x","volume":"30","author":"M Brunner","year":"2004","unstructured":"Brunner M, Krenn C, Roth G, et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med. 2004;30:1468\u201373.","journal-title":"Intensive Care Med"},{"key":"1543_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cyto.2007.11.001","volume":"41","author":"A Becerra","year":"2008","unstructured":"Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I. Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine. 2008;41:114\u201320.","journal-title":"Cytokine"},{"key":"1543_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1006\/bbrc.1997.6810","volume":"235","author":"S Kumar","year":"1997","unstructured":"Kumar S, Tzimas MN, Griswold DE, Young PR. Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem Biophys Res Commun. 1997;235:474\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1543_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0006-291X(02)02578-0","volume":"299","author":"K Oshikawa","year":"2002","unstructured":"Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y. ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem Biophys Res Commun. 2002;299:18\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"1543_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4049\/jimmunol.173.1.145","volume":"173","author":"BP Leung","year":"2004","unstructured":"Leung BP, Xu D, Culshaw S, McInnes IB, Liew FY. A novel therapy of murine collagen-induced arthritis with soluble T1\/ST2. J Immunol. 2004;173:145\u201350.","journal-title":"J Immunol"},{"key":"1543_CR23","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.7611","volume":"12","author":"B Cacopardo","year":"2012","unstructured":"Cacopardo B, Rita Pinzone M, Palermo F, Nunnari G. Changes in serum Interleukin-33 concentration before and after treatment with pegylated interferon alfa-2a plus ribavirin in patients with chronic hepatitis C genotype 1b infection. Hepat Mon. 2012;12, e7611.","journal-title":"Hepat Mon"},{"key":"1543_CR24","first-page":"819636","volume":"2012","author":"J Wang","year":"2012","unstructured":"Wang J, Zhao P, Guo H, et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C. Mediators Inflamm. 2012;2012:819636.","journal-title":"Mediators Inflamm"},{"key":"1543_CR25","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1002\/eji.201041332","volume":"41","author":"MI Arshad","year":"2011","unstructured":"Arshad MI, Rauch M, L'Helgoualc'h A, et al. NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis. Eur J Immunol. 2011;41:2341\u20138.","journal-title":"Eur J Immunol"},{"key":"1543_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2011.03.022","volume":"56","author":"V Volarevic","year":"2012","unstructured":"Volarevic V, Mitrovic M, Milovanovic M, et al. Protective role of IL-33\/ST2 axis in Con A-induced hepatitis. J Hepatol. 2012;56:26\u201333.","journal-title":"J Hepatol"},{"key":"1543_CR27","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1582-4934.2009.00801.x","volume":"14","author":"P Marvie","year":"2010","unstructured":"Marvie P, Lisbonne M, L'Helgoualc'h A, et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med. 2010;14:1726\u201339.","journal-title":"J Cell Mol Med"},{"key":"1543_CR28","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","volume":"123","author":"MA Rank","year":"2009","unstructured":"Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H. IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol. 2009;123:1047\u201354.","journal-title":"J Allergy Clin Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1543-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1543-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T18:22:39Z","timestamp":1506104559000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1543-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1543"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1543-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,16]]},"article-number":"200"}}